YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Syncom Formula
Syncom Formula
BSE: 524470NSE: ISIN: INE312C01025

21st-May-2020 18:48Source: BSE

Syncom Formulations - Submission Of Disclosure Of Impact Of Covid-19 Pandemic On The Company. Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020 and in continuation of our previous intimation submitted to BSE Ltd on 04th March, 2020 & 26th March, 2020.
We would like to inform the stock exchange and stakeholders the Financial Impact of the Pandemic Covid-19 on our Business Operations.
We would like to inform the Exchange that the company has recently resumed partial manufacturing operations in its plant situated at Pithampur and the Corporate Office of the company is also resumed with minimum staff as per the approvals/clearances from the Government of Madhya Pradesh. However, The Registered /Marketing Office at Mumbai has not been opened yet.
Further, we would like to submit the information as required under the SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated 20th May, 2020 as disclosed in Annexure - I.

More Announcements on:

30th-Jun-2020 20:57Source: BSE

Syncom Formulations - Closure of Trading Window

1 2 3 4 5 Next >>